308 related articles for article (PubMed ID: 15638769)
1. Bacterial lantibiotics: strategies to improve therapeutic potential.
Cotter PD; Hill C; Ross RP
Curr Protein Pept Sci; 2005 Feb; 6(1):61-75. PubMed ID: 15638769
[TBL] [Abstract][Full Text] [Related]
2. Lantibiotics: structure, biosynthesis and mode of action.
McAuliffe O; Ross RP; Hill C
FEMS Microbiol Rev; 2001 May; 25(3):285-308. PubMed ID: 11348686
[TBL] [Abstract][Full Text] [Related]
3. Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.
Bierbaum G; Sahl HG
Zentralbl Bakteriol; 1993 Feb; 278(1):1-22. PubMed ID: 8518504
[TBL] [Abstract][Full Text] [Related]
4. Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids.
Lohans CT; Li JL; Vederas JC
J Am Chem Soc; 2014 Sep; 136(38):13150-3. PubMed ID: 25207953
[TBL] [Abstract][Full Text] [Related]
5. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
[TBL] [Abstract][Full Text] [Related]
6. Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides.
Moll GN; Kuipers A; Rink R
Antonie Van Leeuwenhoek; 2010 May; 97(4):319-33. PubMed ID: 20140513
[TBL] [Abstract][Full Text] [Related]
7. Novel lantibiotics and their pre-peptides.
Nes IF; Tagg JR
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):89-97. PubMed ID: 8775969
[TBL] [Abstract][Full Text] [Related]
8. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
[TBL] [Abstract][Full Text] [Related]
9. The genetics of lantibiotic biosynthesis.
Jack R; Bierbaum G; Heidrich C; Sahl HG
Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
[TBL] [Abstract][Full Text] [Related]
10. Unique peptide modifications involved in the biosynthesis of lantibiotics.
Jack RW; Sahl HG
Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
[TBL] [Abstract][Full Text] [Related]
11. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
Entian KD; de Vos WM
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
[TBL] [Abstract][Full Text] [Related]
12. A concise stereoselective synthesis of orthogonally protected lanthionine and beta-methyllanthionine.
Cobb SL; Vederas JC
Org Biomol Chem; 2007 Apr; 5(7):1031-8. PubMed ID: 17377656
[TBL] [Abstract][Full Text] [Related]
13. [Lantibiotics, a class of ribosomally synthesized peptide antibiotics].
Entian KD; Klein C
Naturwissenschaften; 1993 Oct; 80(10):454-60. PubMed ID: 8264800
[TBL] [Abstract][Full Text] [Related]
14. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.
Rink R; Kuipers A; de Boef E; Leenhouts KJ; Driessen AJ; Moll GN; Kuipers OP
Biochemistry; 2005 Jun; 44(24):8873-82. PubMed ID: 15952794
[TBL] [Abstract][Full Text] [Related]
15. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria.
de Vos WM; Kuipers OP; van der Meer JR; Siezen RJ
Mol Microbiol; 1995 Aug; 17(3):427-37. PubMed ID: 8559062
[TBL] [Abstract][Full Text] [Related]
16. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
[TBL] [Abstract][Full Text] [Related]
17. Chapter 21. In vitro studies of lantibiotic biosynthesis.
Li B; Cooper LE; van der Donk WA
Methods Enzymol; 2009; 458():533-58. PubMed ID: 19374997
[TBL] [Abstract][Full Text] [Related]
18. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
Li Q; Montalban-Lopez M; Kuipers OP
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
[TBL] [Abstract][Full Text] [Related]
19. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG
Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044
[TBL] [Abstract][Full Text] [Related]
20. Lantibiotics produced by lactic acid bacteria: structure, function and applications.
Twomey D; Ross RP; Ryan M; Meaney B; Hill C
Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):165-85. PubMed ID: 12369187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
